This Site
Web Search
powered by
YAHOO! SEARCH
Mobile Edition
RSS
Home
News
Community News
Education
Elections
Crime
Gangs
Mexican Veterans
Portraits of the Fallen
Graduations
Health
Sports
Preps
Youth Sports
Area Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Kings
Ducks
Soccer
Motorsports
Live Odds
Scores/Stats
Business
Technology
Financial Markets
Opinions
Editorial
Letters
Columnists
Blogs
Write a Letter
LA.COM
Celebs & Gossip
Movies
TV
Music
Arts
Dining
Nightlife
Shopping & Beauty
Weekend
Comics
Games
Lottery
Horoscopes
Today
Taste
Getting Out
At Home
Info
Contact Us
RSS
Site Map
Subscriber Services
Search Archives
Place An Ad
NIE
Local Biz Center
Obituaries
Homes
Search Homes
Place an Ad
Autos
Search Autos
Place an Ad
Jobs
Find a Job
Post a Job
Classifieds
Search Classfieds
Place an Ad
San Gabriel Valley
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
SPDR S&P Biotech ETF
(NY:
XBI
)
109.11
USD
-0.65 (-0.59%)
Streaming Delayed Price
/ Updated:
3:10 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Fund Documents
Fund Documents
Fund Overview
SPDR S&P Biotech ETF
Sector
Exchange Traded
NY
Net Assets
883.77M
Inception Date
Related Funds
XWIWX
XPPRX
SCHE
ZWB
Quote
Price
109.11
Volume
187,755
Last Trade
May 22, 3:10pm
Change (%)
-0.65 (-0.59%)
Prev. Close
109.76
YTD %
+24.11%
Dividend Yield
0.01%
Performance
YTD
+21.20 (24.11%)
1 Month
+3.23 (3.05%)
3 Month
+12.84 (13.33%)
6 Month
+23.46 (27.39%)
1 Year
+27.75 (34.10%)
Chart
Charting
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Infinity Pharmaceuticals Inc (INFI) Shares Cross Below 200 DMA
May 16, 2013
In trading on Thursday, shares of Infinity Pharmaceuticals Inc (INFI) crossed below their 200 day moving average of $30.69, changing hands as low as $25.95 per share. Infinity Pharmaceuticals Inc...
Read More
from
Market News Video
Momenta Pharmaceuticals Inc (MNTA) Shares Cross Above 200 DMA
May 13, 2013
In trading on Monday, shares of Momenta Pharmaceuticals Inc (MNTA) crossed above their 200 day moving average of $13.01, changing hands as high as $13.17 per share. Momenta Pharmaceuticals Inc shares...
Read More
from
Market News Video
Top News
More News
Positive Prognosis for Biotech ETFs
May 10, 2013
The biotechnology sector has positive long term implications and the indecision that loomed over the industry has subsided, according to S&P Capital. Exchange traded funds that track this sector are a...
Read More
from
ETF Trends
Synageva BioPharma Corp Enters Oversold Territory (GEVA)
May 10, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
from
Market News Video
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks...
Read More
from
Latest Articles from Benzinga.com
Infinity Pharmaceuticals Inc Enters Oversold Territory (INFI)
May 08, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
from
Market News Video
XBI, NPSP, THRX, BIIB: Large Outflows Detected at ETF
May 07, 2013
Symbols mentioned in this story: XBI, NPSP, THRX, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Read More
from
ETF Channel
Investors Clamor for Generic Drug ETF
May 06, 2013
Big pharma will soon lose patents on blockbuster drugs, boosting the market for cheap generic drug producers. Too bad there isn’t an exchange traded fund that tracks global generic drug makers. The...
Read More
from
ETF Trends
Three Top Performing Healthcare Stocks to Watch
May 06, 2013
The healthcare sector has been a very strong performer in 2013, driven in part by a near 12 percent rise in the S&P 500. The iShares Dow Jones US Healthcare ETF (NYSE: IYH ) had climbed better than 19...
Read More
from
Latest Articles from Benzinga.com
GHDX Crosses Above Key Moving Average Level
May 02, 2013
In trading on Thursday, shares of Genomic Health Inc (GHDX) crossed above their 200 day moving average of $30.68, changing hands as high as $30.72 per share. Genomic Health Inc shares are currently...
Read More
from
Market News Video
Oversold Conditions For Achillion Pharmaceuticals Inc. (ACHN)
May 02, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
from
Market News Video
Medivation Breaks Below 200-Day Moving Average - Notable for MDVN
May 01, 2013
In trading on Wednesday, shares of Medivation Inc (MDVN) crossed below their 200 day moving average of $51.11, changing hands as low as $51.05 per share. Medivation Inc shares are currently trading off...
Read More
from
Market News Video
Snag GEVA Even Cheaper Than Its Secondary?
May 01, 2013
Looking back to 114 days ago, Synageva BioPharma Corp (GEVA) priced a 2,150,000 share secondary stock offering at $47.53 per share. Buyers in that offering made a considerable investment into the...
Read More
from
Market News Video
Ironwood Pharmaceuticals Inc. Enters Oversold Territory (IRWD)
May 01, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
from
Market News Video
GEVA Crosses Below Key Moving Average Level
May 01, 2013
In trading on Wednesday, shares of Synageva BioPharma Corp (GEVA) crossed below their 200 day moving average of $49.95, changing hands as low as $49.43 per share. Synageva BioPharma Corp shares are...
Read More
from
Market News Video
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here